We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Injectable Gels Could Repair Disc Degeneration

By HospiMedica International staff writers
Posted on 07 Jun 2011
Nanoscopic polymer particles with unique swelling and mechanical properties that can transform into a gel could help restore the mechanical properties of damaged intervertebral discs (IVDs).

Researchers at the University of Manchester (United Kingdom) have succeeded in developing doubly crosslinked (DX) microgels, a new type of hydrogel that are constructed from covalently linked, singly crosslinked (SX) microgels. More...
Linking the microgel particles together--using covalent linking of physically gelled dispersions of interpenetrating, vinyl-functionalized microgels--formed durable, elastic gels capable of sustaining large permanent changes in shape without breaking. These improved injectable gels have much better mechanical properties than the first generation SX microgels, and the researchers say they now display the necessary long-term durability required for an implanted device.

The relationships between DX microgel composition and mechanical properties were investigated using dynamic rheology and swelling experiments; yield strains could be varied between 5-65%. The ability to tune the mechanical properties of the DX microgels and control of intra- and inter-particle crosslinking is achieved using preparation conditions, including Ph regulation, resulting in microgels that have the potential to be used as injectable gels for soft and load-bearing tissue repair. The study describing the development and properties of the new microgels was published in the May 15, 2011, issue of the journal Soft Matter.

"Degeneration of the intervertebral disc results in chronic back pain which costs the country billions of pounds per annum and causes untold misery for sufferers and their families," said study coauthor Prof. Tony Freemont, PhD, head of research in the school of biomedicine. "We have been working for 25 years to identify methods for treating degeneration of the intervertebral disc."

Related Links:

University of Manchester




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.